Polygenic risk scores and early manifestations of attention-deficit/hyperactivity disorder
- PMID: 37431392
- PMCID: PMC10242910
- DOI: 10.1002/jcv2.12103
Polygenic risk scores and early manifestations of attention-deficit/hyperactivity disorder
Keywords: early detection; early intervention; polygenic risk scores; preschool ADHD.
Conflict of interest statement
Henrik Larsson reports receiving grants from Shire Pharmaceuticals; personal fees from and serving as a speaker for Medice, Shire/Takeda Pharmaceuticals and Evolan Pharma AB; and sponsorship for a conference on attention‐deficit/hyperactivity disorder from Shire/Takeda Pharmaceuticals and Evolan Pharma AB, all outside the submitted work. Henrik Larsson is Editor‐in‐Chief of JCPP Advances. Guilherme, Guilherme V. Polanczyk reports receiving personal fees from and serving as a speaker and/or consultant for Abbott, Ache, Medice, Novo Nordisk, Takeda and royalties from Editora Manole. Guilherme V. Polanczyk is a Joint Editor for JCPP Advances.
Similar articles
-
Attention-deficit/hyperactivity disorder polygenic risk scores predict attention problems in a population-based sample of children.J Am Acad Child Adolesc Psychiatry. 2014 Oct;53(10):1123-9.e6. doi: 10.1016/j.jaac.2014.06.014. Epub 2014 Aug 19. J Am Acad Child Adolesc Psychiatry. 2014. PMID: 25245356
-
Genetic background to attention deficit and hyperactivity disorder and attention deficit and hyperactivity disorder symptoms at the age of 5 years: the role of sleep duration.Sleep. 2023 Jul 11;46(7):zsad047. doi: 10.1093/sleep/zsad047. Sleep. 2023. PMID: 36861221 Free PMC article.
-
Language deficits in specific language impairment, attention deficit/hyperactivity disorder, and autism spectrum disorder: An analysis of polygenic risk.Autism Res. 2020 Mar;13(3):369-381. doi: 10.1002/aur.2211. Epub 2019 Oct 2. Autism Res. 2020. PMID: 31577390 Free PMC article.
-
Diagnosis and Treatment Options for Preschoolers with Attention-Deficit/Hyperactivity Disorder.J Child Adolesc Psychopharmacol. 2020 Mar;30(2):104-118. doi: 10.1089/cap.2019.0116. Epub 2020 Jan 20. J Child Adolesc Psychopharmacol. 2020. PMID: 31967914 Free PMC article. Review.
-
Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Preschool-Aged Children.J Child Adolesc Psychopharmacol. 2018 Nov;28(9):606-614. doi: 10.1089/cap.2018.0057. Epub 2018 Nov 2. J Child Adolesc Psychopharmacol. 2018. PMID: 30388032 Review.
References
-
- Demontis, D. , Walters, R. K. , Martin, J. , Mattheisen, M. , Als, T. D. , Agerbo, E. , Baldursson, G. , Belliveau, R. , Bybjerg‐Grauholm, J. , Bækvad‐Hansen, M. , Cerrato, F. , Chambert, K. , Churchhouse, C. , Dumont, A. , Eriksson, N. , Gandal, M. , Goldstein, J. I. , Grasby, K. L. , Grove, J. , & Neale, B. M. (2019). Discovery of the first genome‐wide significant risk loci for attention deficit/hyperactivity disorder. Nature Genetics, 51(1), 63–75. 10.1038/s41588-018-0269-7 - DOI - PMC - PubMed
-
- Riglin, L. , Tobarra‐Sanchez, E. , Stergiakouli, E. , Havdahl, A. , Tilling, K. , O’Donovan, M. , Nigg, J. , Langley, K. , & Thapar, A. (2022). Early manifestations of genetic liability for ADHD, autism and schizophrenia at ages 18 and 24 months. JCPP Advances, e12093. 10.1002/jcv2.12093 - DOI - PMC - PubMed
-
- Ronald, A. , de Bode, N. , & Polderman, T. J. C. (2021). Systematic review: How the attention‐deficit/hyperactivity disorder polygenic risk score adds to our understanding of ADHD and associated traits. Journal of the American Academy of Child & Adolescent Psychiatry, 60(10), 1234–1277. 10.1016/j.jaac.2021.01.019 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources